Skip to content
healthcare.dev

Bendamustine

NDC 71288-103, Bendamustine HCl, injection, powder, lyophilized, for solution, from Meitheal Pharmaceuticals Inc..

Product NDC
71288-103
Status
Listed
Labeler
Meitheal Pharmaceuticals Inc.
Dosage form
INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION
Route
INTRAVENOUS
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
ANDA
Application
ANDA211001
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/71288-103 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • BENDAMUSTINE HYDROCHLORIDE100 mg/20mL

Pharmacologic classes

Alkylating Activity [MoA]; Alkylating Drug [EPC]

Package NDCNDC-11Package
71288-103-20712880103201 VIAL, SINGLE-DOSE in 1 CARTON (71288-103-20) / 20 mL in 1 VIAL, SINGLE-DOSE

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/40f6f58d-d9ac-4f65-9fc7-16984bf1f180
  • Medicare Part B payment limits (ASP)

    GET /v1/drugs/asp?ndc=71288-103

Use it

Look up 71288-103 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/71288-103 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 71288-103. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.